Exploratory biomarker analysis of trastuzumab deruxtecan versus treatment of physician's choice in HER2-low, hormone receptorepositive metastatic breast cancer in DESTINY-Breast04 Meeting Abstract
| Authors: | Ueno, N. T.; Niikura, N.; Yamashita, T.; Jacot, W.; Cameron, D. A.; Tsurutani, J.; Sohn, J.; Tokunaga, E.; Losada, M. J. V.; Park, Y. H.; Lee, K. S.; Chae, Y. S.; Prat, A.; Suto, F.; Kuwahara, Y.; Boran, A. D.; Kobayashi, M.; Kumar, V.; Aguilar, C. O.; Modi, S. |
| Abstract Title: | Exploratory biomarker analysis of trastuzumab deruxtecan versus treatment of physician's choice in HER2-low, hormone receptorepositive metastatic breast cancer in DESTINY-Breast04 |
| Meeting Title: | ESMO Congress 2024 |
| Journal Title: | Annals of Oncology |
| Volume: | 35 |
| Issue: | Suppl. 2 |
| Meeting Dates: | 2024 Sept 13-17 |
| Meeting Location: | Barcelona, Spain |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2024-09-01 |
| Start Page: | S401 |
| End Page: | S402 |
| Language: | English |
| ACCESSION: | WOS:001326612900427 |
| DOI: | 10.1016/j.annonc.2024.08.379 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 432P -- Source: Wos |
